Nemaline myopathies

Seminars in Pediatric Neurology

Volumn 18, Issue 4, 2011, Pages 230-238

  Wallgren Pettersson, Carina ^a   Sewry, Caroline A ^b,c   Nowak, Kristen J ^d   Laing, Nigel G ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA TROPOMYOSIN; ANTISENSE OLIGONUCLEOTIDE; ATALUREN; BETA TROPOMYOSIN; COFILIN 2; COMPLEMENTARY DNA; NEBULIN; TROPOMYOSIN; TROPONIN T; TYROSINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ACTA1 GENE; AIR CONDITIONING; ARTICLE; CFL2 GENE; CHEMOTHERAPY; CLINICAL FEATURE; DIET SUPPLEMENTATION; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; ELECTRON MICROSCOPY; EXERCISE; EXON SKIPPING; EXPERIMENTAL MOUSE; GENE; GENE MUTATION; GENE REPLACEMENT THERAPY; GENETIC COUNSELING; HISTOPATHOLOGY; HUMAN; KBTBD13 GENE; MOLECULAR DIAGNOSIS; MUSCLE WEAKNESS; NEB GENE; NEMALINE MYOPATHY; NONHUMAN; NONSENSE MUTATION; NOSE FEEDING; ONSET AGE; ORTHOSIS; PATHOGENESIS; RYR1 GENE; SPORADIC LATE ONSET NEMALINE MYOPATHY; STEM CELL TRANSPLANTATION; TNNT1 GENE; TPM2 GENE; TPM3 GENE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, NEMALINE;

EID: 83455263562     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2011.10.004     Document Type: Article

References (73)

1. Lake B.D., Wilson J. Zebra body myopathy. Clinical, histochemical and ultrastructural studies. J Neurol Sci 1975, 24:437-446.
2. Shy G.M., Engel W.K., Somers J.E., et al. Nemaline myopathy. A new congenital myopathy. Brain 1963, 86:793-810.
3. Sambuughin N., Yau K.S., Olivé M., et al. Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with cores. Am J Hum Genet 2010, 87:842-847.
4. Wallgren-Pettersson C., Pelin K., Nowak K.J., et al. Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle α-actin. Neuromuscul Disord 2004, 14:461-470.
5. Chahin N., Selcen D., Engel A.G. Sporadic late onset nemaline myopathy. Neurology 2005, 65:1158-1164.
6. Benveniste O., Laforet P., et al. Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology 2008, 71:531-532.
7. Voermans N.C., Minnema M., Lammens M., et al. Sporadic late-onset nemaline myopathy effectively treated by melphalan and stem cell transplant. Neurology 2008, 71:532-534.
8. Novy J., Rosselet A., Spertini O., et al. Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy. Muscle Nerve 2010, 41:286-287.
9. Laing N.G., Wilton S.D., Akkari P.A., et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet 1995, 9:75-79.
10. Pénisson-Besnier I., Monnier N., Toutain A., et al. A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: A clinical and pathological study. Neuromuscul Disord 2007, 17:330-337.
11. Kiphuth I.C., Krause S., Huttner H.B., et al. Autosomal dominant nemaline myopathy caused by a novel alpha-tropomyosin 3 mutation. J Neurol 2010, 257:658-660.
12. Tan P., Briner J., Boltshauser E., et al. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 1999, 9:573-579.
13. Clarke N.F., Kolski H., Dye D.E., et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 2008, 63:329-337.
14. Lawlor M.W., Dechene E.T., Roumm E., et al. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 2010, 31:176-183.
15. Munot P., Lashley D., Jungbluth H., et al. Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 2010, 20:796-800.
16. Lehtokari V.L., Pelin K., Donner K., et al. Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin. Eur J Hum Genet 2008, 16:1055-1061.
17. De Paula A.M., Franques J., Fernandez C., et al. A TPM3 mutation causing cap myopathy. Neuromuscul Disord 2009, 19:685-688.
18. Lehtokari V.L., Pelin K., Sandbacka M., et al. Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat 2006, 27:946-956.
19. Wallgren-Pettersson C. Congenital nemaline myopathy. A clinical follow-up of twelve patients. J Neurol Sci 1989, 89:1-14.
20. Wallgren-Pettersson C., Lehtokari V.L., Kalimo H., et al. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007, 130:1465-1476.
21. Lehtokari V.L., Pelin K., Herczegfalvi A., et al. Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy. Neuromuscul Disord 2011, 8:556-562.
22. Romero N.B., Lehtokari V.L., Quijano-Roy S., et al. Core-rod myopathy caused by mutations in the nebulin gene. Neurology 2009, 73:1159-1161.
23. Lehtokari V.L., Greenleaf R.S., Dechene E.T., et al. The exon 55 deletion in the nebulin gene-One single founder mutation with world-wide occurrence. Neuromuscul Disord 2009, 19:179-181.
24. Wallgren-Pettersson C., Kivisaari L., Jääskeläinen J., et al. Ultrasonography, CT, and MRI of muscles in congenital nemaline myopathy. Pediatr Neurol 1990, 6:20-28.
25. Jungbluth H., Sewry C.A., Counsell S., et al. Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord 2004, 14:779-784.
26. Laing N.G., Dye D.E., Wallgren-Pettersson C., et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1). Hum Mutat 2009, 30:1267-1277.
27. Nowak K.J., Sewry C.A., Navarro C., et al. Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol 2007, 61:175-184.
28. Sewry C.A., Holton J., Dick D.J., et al. Zebra body myopathy resolved. Neuromuscul Disord 2009, 19:637.
29. Donner K., Ollikainen M., Ridanpää M., et al. Mutations in the β-tropomyosin (TPM2) gene-A rare cause of nemaline myopathy. Neuromuscul Disord 2002, 12:151-158.
30. Sung S.S., Brassington A.M., Grannatt K., et al. Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am J Hum Genet 2003, 72:681-690.
31. Monnier N., Lunardi J., Marty I., et al. Absence of beta-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy. Neuromuscul Disord 2009, 19:118-123.
32. Lehtokari V.L., Ceuterick-de Groote C., de Jonghe P., et al. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2. Neuromuscul Disord 2007, 17:433-442.
33. Tajsharghi H., Ohlsson M., Lindberg C., et al. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2). Arch Neurol 2007, 64:1334-1338.
34. Johnston J.J., Kelley R.I., Crawford T.O., et al. A novel nemaline myopathy in the Amish caused by a mutation in troponin. Am J Hum Genet 2000, 67:814-821.
35. Agrawal P.B., Greenleaf R.S., Tomczak K.K., et al. Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007, 80:162-167.
36. Kaimaktchiev V., Goebel H., Laing N., et al. Intranuclear nemaline rod myopathy. Muscle Nerve 2006, 34:369-372.
37. Dubowitz V., Sewry C.A., et al. Muscle Biopsy: A Practical Approach 2007, Saunders Elsevier, New York, NY. 3rd ed.
38. Jockusch B.M., Veldman H., Griffiths G.W., et al. Immunofluorescence microscopy of a myopathy. Alpha-actinin is a major constituent of nemaline rods. Exp Cell Res 1980, 127:409-420.
39. Luther P.K., Squire J.M. Muscle Z-band ultrastructure: Titin Z-repeats and Z-band periodicities do not match. J Mol Biol 2002, 319:1157-1164.
40. Ilkovski B., Cooper S.T., Nowak K., et al. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 2001, 68:1333-1343.
41. Yamaguchi M., Robson R.M., Stromer M.H., et al. Nemaline myopathy rod bodies. Structure and composition. J Neurol Sci 1982, 56:35-56.
42. Schröder R., Reimann J., Salmikangas P., et al. Beyond LGMD1A: Myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord 2003, 13:451-455.
43. Sharma M.C., Jain D., Sarkar C., et al. Congenital myopathies-A comprehensive update of recent advancements. Acta Neurol Scand 2009, 119:281-292.
44. Gurgel-Giannetti J., Reed U., Bang M.L., et al. Nebulin expression in patients with nemaline myopathy. Neuromuscul Disord 2001, 11:154-162.
45. Vandebrouck A., Domazetovska A., Mokbel N., et al. In vitro analysis of rod composition and actin dynamics in inherited myopathies. J Neuropathol Exp Neurol 2010, 69:429-441.
46. Ravenscroft G., Wilmshurst J.M., Pillay K., et al. A novel ACTA1 mutation resulting in a severe congenital myopathy with nemaline bodies, intranuclear rods and type I fibre predominance. Neuromuscul Disord 2011, 21:31-36.
47. Vihola A., Bassez G., Meola G., et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854-1857.
48. Monnier N., Romero N.B., Lerale J., et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet 2000, 9:2599-2608.
49. Zvaritch E., Kraeva N., Bombardier E., et al. Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods. Proc Natl Acad Sci U S A 2009, 106:21813-21818.
50. Nowak K.J., Ravenscroft G., Jackaman C., et al. Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. J Cell Biol 2009, 185:903-915.
51. Banwell B.L., Russel J., Fukudome T., et al. Myopathy, myasthenic syndrome, and epidermolysis bullosa simplex due to plectin deficiency. J Neuropathol Exp Neurol 1999, 58:832-846.
52. Olivé M., Odgerel Z., Martinez A., et al. Intranuclear rods in three Spanish families with ZASPopathy. Neuromuscul Disord 2010, 20:623. abstract P2.17.
53. Ottenheijm C.A., Hooijman P., DeChene E.T., et al. Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2). J Struct Biol 2010, 170:334-343.
54. Bell C.J., Dinwiddie D.L., Miller N.A., et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011, 3:65ra4.
55. Corbett M.A., Robinson C.S., Dunglison G.F., et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet 2001, 10:317-328.
56. Laing N.G., Majda B.T., Akkari P.A., et al. Assignment of a gene (NEM1) for autosomal dominant nemaline myopathy to chromosome I. Am J Hum Genet 1992, 50:576-583.
57. Bang M.L., Li X., Littlefield R., et al. Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle. J Cell Biol 2006, 173:905-916.
58. Witt C.C., Burkart C., Labeit D., et al. Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J 2006, 25:3843-3855.
59. Crawford K., Flick R., Close L., et al. Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period. Mol Cell Biol 2002, 22:5887-5896.
60. Nguyen M.A., Hardeman E.C. Mouse models for thin filament disease. Adv Exp Med Biol 2008, 642:66-77.
61. Ravenscroft G., Jackaman C., Bringans S., et al. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain 2011, 134(Pt 4):1101-1115.
62. Feng H.Z., Wei B., Jin J.P. Deletion of a genomic segment containing the cardiac troponin I gene knocks down expression of the slow troponin T gene and impairs fatigue tolerance of diaphragm muscle. J Biol Chem 2009, 284:31798-31806.
63. Haigh S.E., Salvi S.S., Sevdali M., et al. Drosophila indirect flight muscle specific Act88F actin mutants as a model system for studying congenital myopathies of the human ACTA1 skeletal muscle actin gene. Neuromuscul Disord 2010, 20:363-374.
64. Guglieri M., Bushby K. Molecular treatments in Duchenne muscular dystrophy. Curr Opin Pharmacol 2010, 10:331-337.
65. Ryan M.M., Sy C., Rudge S., et al. Dietary L-tyrosine supplementation in nemaline myopathy. J Child Neurol 2008, 23:609-613.
66. Nair-Shalliker V., Kee A.J., Joya J.E., et al. Myofiber adaptational response to exercise in a mouse model of nemaline myopathy. Muscle Nerve 2004, 30:470-480.
67. Joya J.E., Kee A.J., Nair-Shalliker V., et al. Muscle weakness in a mouse model of nemaline myopathy can be reversed with exercise and reveals a novel myofiber repair mechanism. Hum Mol Genet 2004, 13:2633-2645.
68. Kinali M., Arechavala-Gomeza V., Feng L., et al. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 2009, 8:918-928.
69. Odom G.L., Banks G.B., Schultz B.R., et al. Preclinical studies for gene therapy of Duchenne muscular dystrophy. J Child Neurol 2010, 25:1149-1157.
70. Meregalli M., Farini A., Parolini D., et al. Stem cell therapies to treat muscular dystrophy: Progress to date. BioDrugs 2010, 24:237-247.
71. Mendell J.R., Campbell K., Rodino-Klapac L., et al. Dystrophin immunity in Duchenne's muscular dystrophy. N Engl J Med 2010, 363:1429-1437. 71.
72. Khurana T.S., Davies K.E. Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2003, 2:379-390.
73. Ilkovski B., Clement S., Sewry C., et al. Defining alpha-skeletal and alpha-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathy. Neuromuscul Disord 2005, 15:829-835.